These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 37323177
1. Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer. Yuan M, Wang C, Wu Y, Qiao L, Deng G, Liang N, Chen F, Liu L, Chen Y, Yang Y, Wang H, Liu T, Yang X, Zhang Y, Lv Y, Suwinski R, Hu P, Zhang Y, Zhang J. Transl Lung Cancer Res; 2023 May 31; 12(5):1093-1107. PubMed ID: 37323177 [Abstract] [Full Text] [Related]
2. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity. Luan X, Lei T, Fang J, Liu X, Fu H, Li Y, Chu W, Jiang P, Tong C, Qi H, Fu Y. Mol Ther; 2024 Feb 07; 32(2):469-489. PubMed ID: 38098230 [Abstract] [Full Text] [Related]
3. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients. Emtenani S, Holtsche MM, Stahlkopf R, Seiler DL, Burn T, Liu H, Parker M, Yilmaz K, Dikmen HO, Lang MH, Sadik CD, Karsten CM, van Beek N, Ludwig RJ, Köhl J, Schmidt E. Front Immunol; 2022 Feb 07; 13():942493. PubMed ID: 36466856 [Abstract] [Full Text] [Related]
4. Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Chen J, Li GQ, Zhang L, Tang M, Cao X, Xu GL, Wu YZ. Cancer Lett; 2018 Jan 01; 412():30-36. PubMed ID: 29031586 [Abstract] [Full Text] [Related]
5. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation. Tang M, Zhang K, Li Y, He QH, Li GQ, Zheng QY, Zhang KQ. Int Urol Nephrol; 2018 Aug 01; 50(8):1545-1553. PubMed ID: 29594894 [Abstract] [Full Text] [Related]
9. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma. Nabizadeh JA, Manthey HD, Panagides N, Steyn FJ, Lee JD, Li XX, Akhir FNM, Chen W, Boyle GM, Taylor SM, Woodruff TM, Rolfe BE. FASEB J; 2019 Oct 01; 33(10):11060-11071. PubMed ID: 31298935 [Abstract] [Full Text] [Related]
10. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis. Chen J, Sun ZH, Chen LY, Xu F, Zhao YP, Li GQ, Tang M, Li Y, Zheng QY, Wang SF, Yang XH, Wu YZ, Xu GL. Aging (Albany NY); 2020 Jul 15; 12(14):14285-14299. PubMed ID: 32669478 [Abstract] [Full Text] [Related]
11. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. Beach C, MacLean D, Majorova D, Melemenidis S, Nambiar DK, Kim RK, Valbuena GN, Guglietta S, Krieg C, Darvish-Damavandi M, Suwa T, Easton A, Hillson LV, McCulloch AK, McMahon RK, Pennel K, Edwards J, O'Cathail SM, Roxburgh CS, Domingo E, Moon EJ, Jiang D, Jiang Y, Zhang Q, Koong AC, Woodruff TM, Graves EE, Maughan T, Buczacki SJ, Stucki M, Le QT, Leedham SJ, Giaccia AJ, Olcina MM. J Clin Invest; 2023 Dec 01; 133(23):. PubMed ID: 37824211 [Abstract] [Full Text] [Related]
12. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury. Song N, Li P, Jiang Y, Sun H, Cui J, Zhao G, Li D, Guo Y, Chen Y, Gao J, Sun S, Zhou Y. Int Immunopharmacol; 2018 Jun 01; 59():12-20. PubMed ID: 29621732 [Abstract] [Full Text] [Related]